Human iPSC-Derived Neural Stem Cells – Huntington’s Disease Patient (CAG50)

Human iPSC-Derived Neural Stem Cells – Huntington’s Disease Patient (CAG50)

Publication date: Oct 01, 2019

We have applied our innovative technology to develop human neural stem cells directly differentiated from Huntington’s Disease iPS cells.

Phase Contrast Image of Huntington’s Disease Human Neural Stem Cells The image was taken at Day 7 in vitro.

Huntington’s Disease Neural Stem Cells Express Neural Stem Cell Markers HD NSCs were fixed after 7 days in culture and stained using our immunocytochemisty protocol.

Concepts Keywords
Cortical Branches of biology
DAPI Cell biology
Excitatory Stem cells
GABA Induced stem cells
Genetic Developmental neuroscience
Huntington Developmental biology
Medium Spiny Neurons Medical terminology
Neurite Neuron
Neuron Neurite
Neurons Striatum
Neurotoxicity Cellular differentiation
Nuclei Drug screening
Pathogenesis Immunocytochemisty protocol
Protocol Cellular models disease
Rosette
Spectrum
Striatal

Semantics

Type Source Name
gene UNIPROT LAT2
gene UNIPROT PPP1R1B
gene UNIPROT CALB1
drug DRUGBANK gamma-Aminobutyric acid
gene UNIPROT BCL11B
gene UNIPROT MAP2
disease DOID neurotoxicity
drug DRUGBANK Spinosad
gene UNIPROT NES
gene UNIPROT IK

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *